Navigation Links
Neumedicines Receives Award of $14 Million from BARDA for Continued Development of HemaMax™ as a Medical Countermeasure to Acute Radiation Exposure
Date:8/14/2014

n that HemaMax™ is safe in healthy volunteers.”

“With BARDA’s continued funding, we are advancing HemaMax™ toward consideration for EUA, which, if granted, would allow for its use in the event of a radiological/nuclear emergency,” she added. “We believe HemaMax™ could have a significant impact in saving lives in such an event, and our team is committed to advancing HemaMax™ so that it may soon be a component of the United States’ arsenal in countering radiological/nuclear emergencies.”

Research and development of HemaMax™ for HSARS has been funded entirely with federal funds from the Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Office of the Secretary, Department of Health and Human Services, under Contract Nos. HHSO1002000800060C and HHSO100201100037C.

“We are also focused on developing rHuIL-12 as an immunotherapy for cancer patients to be used in combination with various cancer treatments, including radiation, chemotherapies, and other immunotherapies. The promise of IL-12 as an immunotherapy is substantiated by the fact that the National Cancer Institute (NCI) and the Cancer Immunotherapy Trials Network (CITN) consider IL-12 a Priority Agent and rank it the top priority vaccine adjuvant and the third overall immunotherapy agent, only behind IL-15 and anti-PD-1,” Dr. Basile stated.

About HemaMax™:

HemaMax™ (rHuIL-12) holds considerable value and promise playing a central role in linking and regulating both innate (early nonspecific) and adaptive (late specific) immunity, while also playing a critical role in hematopoietic cell-to-cell signaling. In addition to HSARS, HemaMax™ is also being developed for various indications in oncology, including cutaneous T cell lymphoma (CTCL), acute myeloid leukemia (AML), melanoma, solid tumors, various immunotherapy applications, and hematopoietic support.

About Neumedicines Inc.:

Neumedicines I
'/>"/>

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Advanced Cell Diagnostics Receives ISO 13485:2003 Certification
2. Rebiotix Inc. Receives $25M for Series B Funding
3. Orexigen Receives CHMP Day 180 List of Outstanding Issues
4. UT Dallas professor receives Engineer of the Year award
5. Global Graphene Manufacturing Leader, Graphene Frontiers, Receives Series Seed B Funding To Assure Production Of The Next Generation Of Biological And Chemical Sensor Technology
6. Young Moscovite Researcher Receives this Years "Basel Declaration Award for Education in Animal Research"
7. ImQuest Pharmaceuticals Receives FDA Approval to Initiate Clinical Trials of a Vaginal Gel for the Prevention of HIV Transmission to Women
8. Worcester Polytechnic Institute Receives NIH Grant to Study Components of a Potentially Potent and Cost-Effective Malaria Treatment
9. RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders
10. Gordon Hunter’s ‘How Are You, Mother Earth?’ Receives Four Stars from Clarion Review
11. DiaVacss Immunotherapy Product for Treatment of Type 1 Diabetes Receives Orphan Drug Status Designation from the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2015  Neurotech Pharmaceuticals, Inc., announced today the ... Phase 2 clinical trial of NT-503 Encapsulated Cell ... subfoveal choroidal neovascularization secondary to age related macular ... endothelial growth factor (VEGF) receptor protein continuously produced ... landmark proof-of-concept study will evaluate NT-503 ECT as ...
(Date:9/2/2015)... Israel , September 2, 2015 ... TASE: BOLT) ("BioLight" or the "Company"), a firm ... in ophthalmology and cancer diagnostics, announced today that ... of glaucoma will be delivered at the Ophthalmology ... the European Society of Cataract & Refractive Surgeons ...
(Date:9/2/2015)... NJ (PRWEB) , ... September 02, 2015 , ... ... Technical Services Staff members will be attending Pharma Ed Resources upcoming educational ... respected group of industry leading speakers, this timely conference will provide Updates & ...
(Date:9/1/2015)... September 2, 2015 ... die Forschung und Entwicklung neuartiger Therapien für ... Darmerkrankungen und Reizdarm konzentriert, erhält vom US ... sein neues Medikament patentiert wird. Das Medikament ... bei Kindern verhindert und Entzündungen vorbeugt.   ...
Breaking Biology Technology:Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 2Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 3Das Patent von Swecure zur Verhinderung von Allergien bei Kindern wird in den USA zugelassen 2
... Cynvec LLC, a privately-held,biopharmaceutical company focused on ... of the Sindbis viral vector, announced today,that it ... Executive,Officer, effective immediately, to lead the company,s next ... CEO, Mr. Stonebanks will serve on Cynvec,s Board,of ...
... MONICA, Calif., Nov. 11 Cord Blood,America, Inc. ... stem,cell preservation company ( http://www.cordblood-america.com ) focused on,bringing ... families nationwide and,internationally, said today that the stem ... Barack Obama intends to use his executive,authority to ...
... of Connecticut,s highest honor for technological achievement, the Medal of ... (T.P.) Ma for his pioneering work in semiconductors. ... the Board of Governors for Higher Education and the ... in alternate years with the Connecticut Medal of Science and ...
Cached Biology Technology:Cynvec LLC(SM) Appoints Former Johnson & Johnson Executive Frank D. Stonebanks as President and Chief Executive Officer 2Cynvec LLC(SM) Appoints Former Johnson & Johnson Executive Frank D. Stonebanks as President and Chief Executive Officer 3Cord Blood America Salutes President-Elect Obama's Promise to Lift Restrictions on Stem Cell Research 2Yale professor T.P. Ma awarded the Connecticut Medal of Technology 2
(Date:8/18/2015)... , Aug. 17, 2015 Research and ... of the "Global Biometric Authentication & Identification ... Estimation & Forecast, 2015-2020" report to their ... and identification systems market is expected to grow ... to 2020 and generate over $25 billion (approximately) ...
(Date:8/12/2015)... , Aug. 12, 2015  Synaptics Inc. ... human interface solutions, today announced that four of ... Match-in-Sensor solution, have officially been named FIDO Certified™ ... part of the certification, Synaptics, Natural ID™ fingerprint ... Universal Authentication Framework (UAF) standard and are interoperable ...
(Date:8/6/2015)... and TELTOW, Germany , August ... Siggraph Conference, SensoMotoric Instruments (SMI) shows the ... , based on Epson,s Moverio BT-200 see-through ... platform. With this new solution, unprecedented quality and efficiency ... interaction with context-sensitive displays. For the first time, professionals ...
Breaking Biology News(10 mins):Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3
... between 10 and 20 percent of cattle in the ... of the most common ailments affecting feedlot and stocker ... team is working to reduce the percentage of cattle ... Anderson, professor of clinical sciences; Brad White, associate professor ...
... create 58 percent of nitrous oxide in the world, which ... Scientists believe nitrous oxide contributes to global warming about 300 ... been introduced to address this issue, but farmers do not ... that may ultimately hurt the "bottom line." Now, researchers at ...
... adults considered overweight and more than one-third categorized as ... maintenance is a major national goal. Mathematical modeling of ... and growing subfield of obesity research, which can be ... for Mathematical and Biological Synthesis (NIMBioS) is now accepting ...
Cached Biology News:Cattle health and welfare at the heart of K-State research 2MU scientists find new farming method to reduce greenhouse gases, increase farm yields 2Body weight regulation and metabolism focus of workshop 2